FFC#4/2017

Phenotyping new genetically-diverse mouse models mirroring the complexity of the Cystic Fibrosis pathology

AREA 3 Bronchopulmonary infection

FFC#4/2017

Phenotyping new genetically-diverse mouse models mirroring the complexity of the Cystic Fibrosis pathology
€ 0 still needed
0%
€ 92.000 goal

pRINCIPAL INVESTIGATOR

Nicola Ivan Lorè (Unità di Infezioni e Fibrosi cistica, Divisione di Immunologia, Trapianti e Malattie Infettive, Ospedale San Raffaele, Milano)

Researchers

6

Category

AREA 3 Bronchopulmonary infection

Duration

2 years

Goal

€ 92.000

Funds raised

€ 92.000

Objectives

In animal models, the existing CF mice do not represent the heterogeneity of the human population and are often lacking pulmonary phenotype. Recently a new mouse model, Collaborative Cross (CC) has been generated to overcome the limitation of existing resources. Thanks to a previous FFC project (FFC#11/2015), the existing CF F508del-/- mouse in C57Bl/6 background has been backcrossed in two CC murine lines, selected for their extreme genotypic and phenotypic diversity, that is the most susceptible (CC-S) and the most resistant (CC-R) to P. aeruginosa. Novel and unique CC-S-F508del-/- and CC-R-F508del-/- mice lines were generated. In this project, they will be characterized in the naïve status or after P. aeruginosa airway infection. Host defence, immune profile and molecular mechanisms against bacterial respiratory infections will be studied. Due to their high allelic diversity, these new mice models may reproduce diverse disease phenotypes (infection/inflammation), as observed in CF patients, offering a tool to better understand disease variability e to modulate and personalize CF therapies.

WHO ADOPTED THE PROJECT

Delegazione FFC di Milano

€ 92.000

Delegazione FFC di Vittoria, Ragusa e Siracusa

€ 19.000

Delegazione FFC di Catania Mascalucia

€ 19.000

OTHER PROJECTS

Discover the other projects

GMSG#1/2025

Developing PNAs to Block Essential Bacterial Genes and Create New Antimicrobial Therapies

FFC#1/2025

Understanding the process of epithelial-mesenchymal transition to preserve tissue function and reduce long-term complications (e.g. cancer)

FFC#2/2025

Developing RNA-targeted therapies to regulate gene expression and restore CFTR synthesis